EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Comparing the efficacy and safety of thromboprophylaxis with enoxaparin versus normal saline after liver transplantation: randomized clinical trial

Kunlin Xie iD, Hongzhao Yang iD, Shouping Wang, Chenghan Xiao, Tian Lan, Hanyu Jiang, Sheyu Li iD, Huakang Tu, Jian Yang, Tao Lyv, Jianguo Qiu iD, Jing Zhou und 9 weitere

British Journal of Surgery · 2025

DOI: 10.1093/bjs/znae325 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Surgery, 2025. Verfasst von Kunlin Xie und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Enoxaparin, Liver Transplantation, Anticoagulants, Venous Thrombosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Venous thrombosis represents a significant complication after deceased-donor liver transplantation, yet there are currently no established protocols for thromboprophylaxis after deceased-donor liver transplantation. The aim of this study was to evaluate the efficacy and safety of prophylactic anticoagulation in patients undergoing deceased-donor liver transplantation.

Methods

A dual-centre RCT of patients assigned to receive either enoxaparin or normal saline after liver transplantation was conducted. The primary efficacy outcome was the incidence of venous thrombosis (portal vein thrombosis and deep vein thrombosis) and the primary safety outcome was the incidence of major bleeding.

Results

A total of 462 patients were recruited. In the intention-to-treat analysis, 89 patients (19.3%) experienced venous thrombosis and 141 patients (30.5%) experienced major bleeding within 90 days after transplantation. No significant differences were observed in the incidence of venous thrombosis, portal vein thrombosis, or deep vein thrombosis between the two groups in the intention-to-treat cohort. The anticoagulant group demonstrated a markedly elevated incidence of major bleeding (35.5% versus 25.5%, P = 0.020). Subgroup analysis revealed that anticoagulation was associated with a lower risk of deep vein thrombosis in hepatocellular carcinoma patients (HR 0.44 (95% c.i. 0.23 to 0.86), P = 0.016), without a significantly higher risk of major bleeding.

Conclusion

Use of prophylactic anticoagulation with enoxaparin is associated with a significantly higher incidence of major bleeding in patients undergoing deceased-donor liver transplantation, rather than a lower likelihood of venous thrombosis. Registration number ChiCTR2000032441 (www.chictr.org.cn).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EnoxaparinLiver TransplantationAnticoagulantsVenous ThrombosisSaline SolutionPostoperative ComplicationsHumansMaleFemaleMiddle AgedAdultTreatment OutcomePortal VeinAgedHemorrhage

Substanzen

EnoxaparinAnticoagulantsSaline Solution

Autor:innen und Institutionen

  • Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Liver Transplant Centre, Transplant Centre, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Maternal and Child Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
  • Institute of Systems Epidemiology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
  • Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Kunlin Xie, Hongzhao Yang, Sheyu Li, Jianguo Qiu, Yong Zeng, Hong Wu

Förderung

  • West China Hospital, Sichuan University

Zitieren

APA

Xie, K., Yang, H., Wang, S., Xiao, C., Lan, T., Jiang, H., Li, S., Tu, H., Yang, J., Lyv, T., Qiu, J., Zhou, J., Zhang, Z., Du, C., Wu, X., Huang, J., Elgendi, A. M., Kow, A. W. C., Yang, J., …, & Wu, H. (2025). Comparing the efficacy and safety of thromboprophylaxis with enoxaparin versus normal saline after liver transplantation: randomized clinical trial. British Journal of Surgery. https://doi.org/10.1093/bjs/znae325

Vancouver

Xie K, Yang H, Wang S, Xiao C, Lan T, Jiang H, et al. Comparing the efficacy and safety of thromboprophylaxis with enoxaparin versus normal saline after liver transplantation: randomized clinical trial. British Journal of Surgery. 2025. doi:10.1093/bjs/znae325

BibTeX
@article{Xie2025,
  author = {Xie, Kunlin and Yang, Hongzhao and Wang, Shouping and Xiao, Chenghan and Lan, Tian and Jiang, Hanyu and Li, Sheyu and Tu, Huakang and Yang, Jian and Lyv, Tao and Qiu, Jianguo and Zhou, Jing and Zhang, Zhongwei and Du, Chengyou and Wu, Xifeng and Huang, Jiwei and Elgendi, Ahmed M and Kow, Alfred W C and Yang, Jiayin and Zeng, Yong and Wu, Hong},
  title = {Comparing the efficacy and safety of thromboprophylaxis with enoxaparin versus normal saline after liver transplantation: randomized clinical trial},
  journal = {British Journal of Surgery},
  year = {2025},
  doi = {10.1093/bjs/znae325}
}
Kostenlos starten →